Skip to main content
Toggle navigation
Login
Search
Home
Tweets by 2023 SSO Annual Meeting
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Home
Browse by Speaker
Browse by Speaker
Browse by Speaker
Type here to filter the list
All
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
S
Saadat, Lily
Memorial Sloan Kettering Cancer Center
37: Hepatic Artery Infusion Chemotherapy Compared to Y90 for Treatment of Unresectable Colorectal Liver Metastases: A Multi-Institutional Comparative Study
Location:Ballroom B
Lily Saadat
Sacco, Joseph
Clatterbridge Cancer Centre and University of Liverpool
60: Safety, efficacy, and biomarker assessment of RP1 in combination with nivolumab in patients with advanced skin cancers
Location:Veterans Memorial Auditorium
Joseph Sacco
Saeed, Samir
Brown University
97: Long-term Oncologic Outcomes Following Pathologic Complete Response (pCR) for Esophageal Cancer
Location:Ballroom A
Samir Saeed
Saey, Stephanie
University of Iowa Hospitals
42: Machine-learning based investigation of prognostic indicators for oncological outcome of pancreatic ductal adenocarcinoma
Location:Ballroom B
Stephanie Saey
Sag, Alan
Duke University Medical Center
P60: Evolution in management of upfront treatment for desmoid tumors
Location:SSO HUB: Melanoma & Sarcoma Zone
Alan Sag
Sagie, Boaz
Tel Aviv Sourasky Medical Center
P81: Neoadjuvant Chemotherapy for Gastric Cancer in the Elderly: Are We Accomplishing Our Treatment Goals or Should we Consider an Upfront Surgery Approach
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Boaz Sagie
Salama, April
Duke University Medical Center
58: Timing of Adjuvant Immunotherapy in Stage III Melanoma, Does it Matter?
Location:Veterans Memorial Auditorium
April Salama
Saldanha, Gerald
University Hospitals of Leicester NHS Trust, Leicester, UK
62: Validation of Invasive Area for Predicting Sentinel Node Status and Survival in Melanoma
Location:Veterans Memorial Auditorium
Gerald Saldanha
Salgado Pogacnik, Javier
UT Southwestern Medical Center
P18: Perioperative Outcomes of Robotic and Laparoscopic Surgery for Colorectal Cancer: A Propensity Score Matched Analysis
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Javier Salgado Pogacnik
Saltz, Leonard
Department of Medicine, Memorial Sloan Kettering Cancer Center
21: Organ Preservation, Compliance and Toxicity in Rectal Cancer Patients Treated with Total Neoadjuvant Therapy: A Post Hoc Analysis of the of the OPRA Phase II Trial
Location:Ballroom C
Leonard Saltz
Samantha, Falls
Allegheny Health Network
P55: Defining Values and Quality of Life of Cancer Survivors following Cytoreductive Surgery and HIPEC: An International Study
Location:SSO HUB: Rare/Metastatic Cancers Zone
Falls Samantha
Sammons, Sarah
Duke University
11: Genomic Landscape of Malignant Phyllodes Tumors Reveals Multiple Targetable Opportunities
Location:Veterans Memorial Auditorium
Sarah Sammons
Samson, Adel
University of Leeds
60: Safety, efficacy, and biomarker assessment of RP1 in combination with nivolumab in patients with advanced skin cancers
Location:Veterans Memorial Auditorium
Adel Samson
Sanchez, Julian
H. Lee Moffitt Cancer Center & Research Institute
Cancer in the Transgender Community
Location:SSO HUB Theater
Julian Sanchez
Questions and Discussion
Location:Ballroom C
Julian Sanchez
Research to Understand the Cancer Burden of the LGBTQ Community
Location:Ballroom C
Julian Sanchez
Surveillance and Treatment of Anal Dysplasia
Location:SSO HUB Theater
Julian Sanchez
Sanfilippo, Roberta
Fondazione IRCCS Istituto Nazionale Tumori
P58: Immune infiltrate of primary retroperitoneal sarcomas (RPS): a prognostic study
Location:SSO HUB: Melanoma & Sarcoma Zone
Roberta Sanfilippo
P64: Surgical management of the duodenum during multivisceral resection for retroperitoneal sarcoma (RPS)
Location:SSO HUB: Melanoma & Sarcoma Zone
Roberta Sanfilippo
Sangalli, Claudia
Fondazione IRCCS Istituto Nazionale dei Tumori, Milan
P58: Immune infiltrate of primary retroperitoneal sarcomas (RPS): a prognostic study
Location:SSO HUB: Melanoma & Sarcoma Zone
Claudia Sangalli
P64: Surgical management of the duodenum during multivisceral resection for retroperitoneal sarcoma (RPS)
Location:SSO HUB: Melanoma & Sarcoma Zone
Claudia Sangalli
Sanjive, Jeevan Geetha
NIMS MEDICTY
GPPO21: A Single Institutional Prospective Observational Study On ER, PR, HER 2- NEU, KI 67 ExpressionAnd Discordance Pattern In Primary and Metastatic and Recurrent Carcinoma Breast and ItsTherapeutic Implications and Prognostic Outcome
Location:Ballroom C
Jeevan Geetha Sanjive
Sanmamed, Miguel
Clínica Universidad de Navarra
60: Safety, efficacy, and biomarker assessment of RP1 in combination with nivolumab in patients with advanced skin cancers
Location:Veterans Memorial Auditorium
Miguel Sanmamed
Sardi, Armando
The Institute for Cancer Care, Mercy Medical Center
24: Sufficient Regional Lymph Node Examination for Staging High-Grade Appendix Cancer
Location:Ballroom C
Armando Sardi
Maximal Tumor Debulking
Location:Ballroom C
Armando Sardi
Sarna, Angela
The Ohio State University
P76: Surgeon Perspectives on Management of Aborted Cancer Surgery: Results of an SSO Member Survey
Location:SSO HUB: Rare/Metastatic Cancers Zone
Angela Sarna
Sarnaik, Amod
H. Lee Moffitt Cancer Center, Tampa, FL, USA
64: Lifileucel TIL Cell Therapy in Patients With Advanced Melanoma After Progression on Immune Checkpoint Inhibitors (ICI) and Targeted Therapy: Tumor Tissue Procurement Data from the C-144-01 Study
Location:Veterans Memorial Auditorium
Amod Sarnaik
Sarpel, Umut
Icahn School of Medicine at Mount Sinai
P80: Accuracy of Clinical Staging for Intramural (T2) Gastric Cancer: Survival Outcomes Following Upfront Surgical Resection Compared to Risk of Overtreatment with Neoadjuvant Therapy
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Umut Sarpel
Sarvestani, Amber Leila
Surgical Oncology Program, Center for Cancer Research, National Cancer Institute
40: Pre-clinical and clinical evaluation of tivozanib for Exportin 7/Ste20-like-kinase (XPO7/SLK)-expressing cholangiocarcinoma
Location:Ballroom B
Amber Leila Sarvestani
Sato, Kenji
Department of Musculoskeletal Oncology, National Cancer Center Hospital, Tokyo, Japan
77: Current Patterns of Care and Outcomes for Dermatofibrosarcoma Protuberans: An International Multi-institutional Collaborative
Location:Ballroom A
Kenji Sato
Saunders, Aaron
Summit Cancer Center
Between Patient and Policy Maker - What We Can do to Build Global Capacity for Cancer Surgery
Location:Ballroom A
Aaron Saunders
Saunders, Neil
Emory University School of Medicine
Parathyroid Cancer - What is new
Location:SSO HUB: Breast & Endocrine Zone
Neil Saunders
Saw, Robyn
Melanoma Institute Australia, Royal Prince Alfred Hospital, University of Sydney
59: Validating the Use of Surrogate Endpoints to Assess the Survival Outcomes of Melanoma Patients in Clinical Trials
Location:Veterans Memorial Auditorium
Robyn Saw
Saylor, Philip
Massachusetts General Hospital / Harvard Medical School
Adrenal Metastases in the Era of Targeted/Immunotherapy from an Oncologist's Perspective
Location:Ballroom C
Philip Saylor
Questions and Discussion
Location:Ballroom C
Philip Saylor
Scally, Christopher
University of Texas MD Anderson Cancer Center
PSM Poster Presentations 1
Location:SSO HUB: Rare/Metastatic Cancers Zone
Christopher Scally
Schadendorf, Dirk
Comprehensive Cancer Center, Universitaetsklinikum Essen & German Cancer Consortium, Essen, Germany
54: Adjuvant Pembrolizumab in Stage II Melanoma: Outcomes by Tumor Location in the Phase 3 KEYNOTE-716 Study
Location:Veterans Memorial Auditorium
Dirk Schadendorf
Schaefer, Sara
University of Michigan
86: Identifying Characteristics of High-Performing Hospital Networks for Major Cancer Surgery
Location:Ballroom B
Sara Schaefer
Scheri, Randall
Duke University
When do I use Molecular Testing for Thyroid Nodules (What to do with NIFTP Also)
Location:SSO HUB: Breast & Endocrine Zone
Randall Scheri
Schiffman, Suzanne
Allegheny Health Network Cancer Institute
69: Peritoneal fluid cytokine analysis reveals targets for regional immunotherapy in carcinomatosis
Location:Ballroom B
Suzanne Schiffman
Schlick, Cary Jo
Memorial Sloan Kettering Cancer Center
P71: Are Pathologic Factors Associated with Higher Risk for Venous Thromboembolism After Gastrointestinal Cancer Surgery? A Potential Opportunity to Tailor Prophylaxis
Location:SSO HUB: Rare/Metastatic Cancers Zone
Cary Jo Schlick
Schmidt, Carl
West Virginia University
104: Neoadjuvant Imatinib Permits Robotic Duodenal Sleeve Resection for Gastrointestinal Stromal Tumor
Location:Veterans Memorial Auditorium
Carl Schmidt
Schmitz, Robin
Duke University Medical Center
P29: Hepatic resection for metastatic pancreatic ductal adenocarcinoma – a prospective single institution pilot study
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Robin Schmitz
Schoeniger, Luke
University of Rochester Medical Center
38: Semaphorin 4D is Expressed by Activated Lymphocytes in Pancreatic Adenocarcinoma, and Monoclonal Blockade Sensitizes Murine Tumors to Immune Checkpoint Therapy
Location:Ballroom B
Luke Schoeniger
Schulick, Richard
University of Colorado School of Medicine, Department of Surgery, Division of Surgical Oncology
P19: Pathological Features Associated With Lymph Node Disease in Patients with Appendiceal Neuroendocrine Tumors.
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Richard Schulick
P38: Dynamic anthropometrics: sarcopenia and survival in pancreatic cancer
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Richard Schulick
Schultz, Nikolaus
Memorial Sloan Kettering Cancer Center
35: Genetic Heterogeneity of Intrahepatic Cholangiocarcinoma: Implications for Outcome
Location:Veterans Memorial Auditorium
Nikolaus Schultz
Schulze, Amy
Mayo Clinic Rochester
P4: Clinical Behavior, Management and Treatment Response of Estrogen Receptor Low (1-10%) Breast Cancer by PR expression
Location:SSO HUB: Breast & Endocrine Zone
Amy Schulze
Schwartz, Patrick
University of Wisconsin School of Medicine and Public Health
37: Hepatic Artery Infusion Chemotherapy Compared to Y90 for Treatment of Unresectable Colorectal Liver Metastases: A Multi-Institutional Comparative Study
Location:Ballroom B
Patrick Schwartz
Scoggins, Charles
University of Louisville
88: Optimal Radiation Dose Intensity: Low- vs. High-Dose in the Neo-Adjuvant Treatment of Locally Advanced Esophageal Cancer
Location:Ballroom B
Charles Scoggins
Scolyer, Richard
Melanoma Institute Australia and Faculty of Medicine and Health, The University of Sydney, Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital and NSW Health Pathology, Sydney,
56: International Validation Study of the Melanoma Institute Australia Sentinel Node Metastasis Risk Nomogram
Location:Veterans Memorial Auditorium
Richard Scolyer
P41: A Multi-Institution Observational Analysis of the Theory of the Immunization Effect in Patients with Multiple Primary Melanomas
Location:SSO HUB: Melanoma & Sarcoma Zone
Richard Scolyer
P43: Prognostic assessment of sentinel lymph node metastases: Are we using the wrong measure of tumor burden?
Location:SSO HUB: Melanoma & Sarcoma Zone
Richard Scolyer
P44: A Tool For Predicting The Risk Of Death From Melanoma And Competing Causes At Varying Time Intervals After Diagnosis
Location:SSO HUB: Melanoma & Sarcoma Zone
Richard Scolyer
Scott, Aaron
City of Hope National Medical Center
P35: Slow Adoption of Observation for Small Pancreatic Neuroendocrine Tumors
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Aaron Scott
Scott, Erin
The Ohio State University Wexner Medical Center
P76: Surgeon Perspectives on Management of Aborted Cancer Surgery: Results of an SSO Member Survey
Location:SSO HUB: Rare/Metastatic Cancers Zone
Erin Scott
Segal, Brahm
Roswell Park Comprehensive Cancer Center
94: Single-cell profiling of tumor-infiltrating T-cell clones in longitudinal peripheral blood samples for clinical studies
Location:Ballroom A
Brahm Segal
Senthil, Maheswari
University of California, Irvine
Lap HIPEC
Location:SSO HUB Theater
Maheswari Senthil
P49: Convolutional Neural Network to Predict Peritoneal Carcinomatosis Risk in Gastric Cancer
Location:SSO HUB: Rare/Metastatic Cancers Zone
Maheswari Senthil
P50: Novel Vascularized Microtumor (VMT) Model of Peritoneal Carcinomatosis (PC) with Mesothelial-Lined Chambers and Submesothelial Stroma that Mimic the Peritoneal Cavity
Location:SSO HUB: Rare/Metastatic Cancers Zone
Maheswari Senthil
P65: A National Assessment of Differences in Gastric Cancer Outcomes Among Asian Ethnic Subgroups
Location:SSO HUB: Rare/Metastatic Cancers Zone
Maheswari Senthil
PSM Parallel Session
Location:Ballroom B
Maheswari Senthil
Seo, Y. David
University of Texas MD Anderson Cancer Center
95: Cancer Testis Antigen and Interleukin Expression Correlates with Survival in Small Bowel Neuroendocrine Tumors
Location:Ballroom A
Y. David Seo
Seth, Prem
NorthShore University HealthSystem
25: Combination Immunotherapy with Oncolytic Virus Induces Immunogenic Cell Death and T-cell Proliferation in Colon Cancer
Location:Ballroom C
Prem Seth
Sevilimedu, Varadan
Memorial Sloan Kettering Cancer Center
P1: Axillary dissection is avoidable in the majority of cT1N0 triple negative and HER2+ breast cancers having upfront surgery with adjuvant radiation
Location:SSO HUB: Breast & Endocrine Zone
Varadan Sevilimedu
P11: Satisfaction and well-being after contralateral prophylactic mastectomy among BRCA mutation carriers and non-carriers: a longitudinal analysis of BREAST-Q domains
Location:SSO HUB: Breast & Endocrine Zone
Varadan Sevilimedu
P3: Diagnosing lymphedema after axillary surgery: which method is superior?
Location:SSO HUB: Breast & Endocrine Zone
Varadan Sevilimedu
P73: How much does postoperative pain interfere with activities of daily living after breast surgery?
Location:SSO HUB: Rare/Metastatic Cancers Zone
Varadan Sevilimedu
Shackelford, David
UCLA Health
79: Dysregulation of Mitochondrial Dynamics via Dynamin-Related Protein 1 Implicated in Dedifferentiated Liposarcoma
Location:Ballroom A
David Shackelford
Shah, Arusa
University of Montreal
P12: Impact of Margin Status on Local Recurrence in Patients with Breast Cancer Undergoing Breast Conserving Surgery After Neoadjuvant Chemotherapy
Location:SSO HUB: Breast & Endocrine Zone
Arusa Shah
Shah, Kevin
Duke University
P33: Personalized Circulating Tumor DNA and Survival in Patients with Resectable Pancreatic Cancer
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Kevin Shah
Shah, Mihir M.
Emory University Winship Cancer Institute
43: Optimal Duration of Chemotherapy in the Era of Neoadjuvant Therapy for Pancreatic Adenocarcinoma - Is There a Magic Number?
Location:Ballroom B
Mihir M. Shah
HPB Poster Presentations 1
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Mihir M. Shah
Shah, Rupen
Henry Ford Health
Global Partner Poster Presentations
Location:Ballroom C
Rupen Shah
Shaikh, Nizamuddin
Mayo Clinic
P84: Outcomes After Minimally Invasive Gastrectomy for Locally Advanced Gastric Cancer
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Nizamuddin Shaikh
Shaitelman, Simona
MD Anderson Cancer Center
7: Multicenter clinical trial for omission of breast surgery in invasive cancer following neoadjuvant systemic therapy: Longitudinal patient reported outcomes and decisional comfort planned analyses
Location:Veterans Memorial Auditorium
Simona Shaitelman
Shannon, Kerwin
Melanoma Institute of Australia, University of Sydney, Sydney, Australia
59: Validating the Use of Surrogate Endpoints to Assess the Survival Outcomes of Melanoma Patients in Clinical Trials
Location:Veterans Memorial Auditorium
Kerwin Shannon
Sharib, Jeremy
University of Washington
52: Adjuvant chemotherapy for resected intrahepatic cholangiocarcinoma confers no survival advantage.
Location:Ballroom A
Jeremy Sharib
Sharma, Ashwyn
UC San Diego
76: Single nuclei RNAseq Reveals Dedifferentiation States from Human ICCs to GIST
Location:Ballroom A
Ashwyn Sharma
Sharon, Cimarron
Hospital of the University of Pennsylvania, US
56: International Validation Study of the Melanoma Institute Australia Sentinel Node Metastasis Risk Nomogram
Location:Veterans Memorial Auditorium
Cimarron Sharon
Sharon, Elad
National Cancer Institute, Bethesda, MD, USA
53: Surgical Outcomes of SWOG1801: Neoadjuvant/adjuvant versus adjuvant pembrolizumab for resectable stage III-IV melanoma
Location:Veterans Memorial Auditorium
Elad Sharon
57: Neoadjuvant Pembrolizumab in Stage II-III Desmoplastic Melanoma (SWOG S1512): Surgical Considerations
Location:Veterans Memorial Auditorium
Elad Sharon
Shen, Duanwen
Washington University in St. Louis
22: The Long non-coding RNA RAMS11 Promotes Chemotherapy Resistance in-vivo in Metastatic Colorectal Cancer.
Location:Ballroom C
Duanwen Shen
Shen, Perry
Atrium Health Wake Forest Baptist
65: Detection of Residual Peritoneal Metastases Following Cytoreductive Surgery Using Pegsitacianine, a pH Sensitive Imaging Agent: Topline Results from a Phase 2 Study
Location:Veterans Memorial Auditorium
Perry Shen
66: Utilizing Organoids to Study Perfusate Selection in Appendiceal Cancer Patients Undergoing Repeat HIPEC
Location:Ballroom B
Perry Shen
68: Assessing the Mucolytic and Cytotoxic Activity of Bromelain in Appendiceal Cancer Organoids
Location:Ballroom B
Perry Shen
Shen, Yu
MD Anderson Cancer Center
5: Extremely Low Incidence of Local-Regional Recurrences Observed Among T1-2 N1 (1 or 2 Positive SLNs) Breast Cancer Patients Receiving Upfront Mastectomy Without Completion Axillary Node Dissection
Location:Veterans Memorial Auditorium
Yu Shen
Sheriff, Salma
Medical College of Wisconsin
87: Identifying Optimal Surgical Timing Relative to SARS-CoV-2 Infection Using COVID-19 Severity in Cancer Patients
Location:Ballroom B
Salma Sheriff
Shimada, Shoji
Memorial Sloan Kettering Cancer Center
93: Effectiveness of Sentinel Lymph Node Mapping in Gastric Cancer
Location:Ballroom A
Shoji Shimada
P82: Short- and Long- Term Outcomes of Minimally Invasive vs Open Gastrectomy after Neoadjuvant Chemotherapy for Gastric cancer.
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Shoji Shimada
Shin, Paul
Memorial Sloan Kettering Cancer Center
35: Genetic Heterogeneity of Intrahepatic Cholangiocarcinoma: Implications for Outcome
Location:Veterans Memorial Auditorium
Paul Shin
Shi, Wen
Iovance Biotherapeutics, Inc., San Carlos, CA, USA
64: Lifileucel TIL Cell Therapy in Patients With Advanced Melanoma After Progression on Immune Checkpoint Inhibitors (ICI) and Targeted Therapy: Tumor Tissue Procurement Data from the C-144-01 Study
Location:Veterans Memorial Auditorium
Wen Shi
Sholevar, Cyrus
UC Davis
P37: Characterization of Natural Killer and Cytotoxic T Cell Immune Infiltrates in Pancreatic Ductal Adenocarcinoma
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Cyrus Sholevar
Shoup, Margo
Orlando Health Cancer Institute
Panel: Pursuing a Career in Academia Versus Private Practice
Location:Room 302
Margo Shoup
Surgeons Leading outside the OR: Health System Leadership Opportunities Outside Traditional Academic Practice
Location:Room 302
Margo Shoup
Shrader, Hannah
University of Iowa Hospitals and Clinics
42: Machine-learning based investigation of prognostic indicators for oncological outcome of pancreatic ductal adenocarcinoma
Location:Ballroom B
Hannah Shrader
Shuai, Yongli
University of Pittsburgh Medical Center Hillman Biostatistics Facility
P52: Impact of Primary Tumor Location and Genomic Alterations on Survival Following Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemoperfusion for Colorectal Peritoneal Metastases
Location:SSO HUB: Rare/Metastatic Cancers Zone
Yongli Shuai
Shui, Amy
Massachusetts General Hospital
9: Breast cancer-related lymphedema and its relationship to major landmark trials in surgical oncology and radiation oncology
Location:Veterans Memorial Auditorium
Amy Shui
Sicklick, Jason
Moores Cancer Center | UC San Diego Health
76: Single nuclei RNAseq Reveals Dedifferentiation States from Human ICCs to GIST
Location:Ballroom A
Jason Sicklick
R Type Grants
Location:Room 304
Jason Sicklick
Surgical Cytoreduction for Metastatic GIST: Who, When, and Why?
Location:SSO HUB: Melanoma & Sarcoma Zone
Jason Sicklick
Siddiqi, Amn
Johns Hopkins University Department of Surgery
28: Tumor Deposits Are Associated with a Higher Risk of Peritoneal Disease in Non-Metastatic Colorectal Cancer Patients
Location:Ballroom C
Amn Siddiqi
Sideris, Lucas
University of Montreal
Questions and Discussion
Location:Ballroom C
Lucas Sideris
Two-step Cytoreduction
Location:Ballroom C
Lucas Sideris
Siegel, Emily
University of Southern California
Cancer Care and Survivorship Needs for LGBTQ Patients
Location:SSO HUB: Breast & Endocrine Zone
Emily Siegel
Considerations for LGBTQ Breast Patients
Location:SSO HUB: Breast & Endocrine Zone
Emily Siegel
Sigel, Carlie
Memorial Sloan Kettering Cancer Center
35: Genetic Heterogeneity of Intrahepatic Cholangiocarcinoma: Implications for Outcome
Location:Veterans Memorial Auditorium
Carlie Sigel
Silver, Casey
Northwestern University
P70: A call for more equitable care in colon cancer: The association between racial and socioeconomic disparities and hospital quality
Location:SSO HUB: Rare/Metastatic Cancers Zone
Casey Silver
P71: Are Pathologic Factors Associated with Higher Risk for Venous Thromboembolism After Gastrointestinal Cancer Surgery? A Potential Opportunity to Tailor Prophylaxis
Location:SSO HUB: Rare/Metastatic Cancers Zone
Casey Silver
Silviera, Matthew
Washington University School of Medicine in St. Louis
26: Neoadjuvant Chemoradiation Does Not Improve Outcomes for Patients Undergoing Resection for Upper Rectal Cancer: A US Rectal Cancer Consortium Analysis
Location:Ballroom C
Matthew Silviera
Sim, Myung
University of California Los Angeles
P43: Prognostic assessment of sentinel lymph node metastases: Are we using the wrong measure of tumor burden?
Location:SSO HUB: Melanoma & Sarcoma Zone
Myung Sim
Singer, Samuel
Memorial Sloan Kettering Cancer Center
74: Interim Results of a Phase II Trial of Regional Melphalan via Limb Infusion and Systemic PD1 Blockade in Patients with Extremity Sarcoma
Location:Veterans Memorial Auditorium
Samuel Singer
Singh, Gagandeep
City of Hope National Medical Center
P35: Slow Adoption of Observation for Small Pancreatic Neuroendocrine Tumors
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Gagandeep Singh
Singhi, Aatur
University of Pittsburgh Medical Center
73: Predicting Early Recurrence to optimize Patient Selection for Cytoreductive Surgery-Hyperthermic Intraperitoneal Chemotherapy in High-Grade Appendiceal Mucinous Carcinoma Peritonei
Location:Ballroom B
Aatur Singhi
P52: Impact of Primary Tumor Location and Genomic Alterations on Survival Following Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemoperfusion for Colorectal Peritoneal Metastases
Location:SSO HUB: Rare/Metastatic Cancers Zone
Aatur Singhi
Singh, Puneet
UT MD Anderson Cancer Center
Meet the Experts: Controversies in Breast Cancer Surgery
Location:Room 302
Puneet Singh
Singh, Samara
University of Miami, Miller School of Medicine, Department of Surgery
P32: p38 MAPK inhibition reprograms the inflammatory stroma to overcome the immunosuppressive tumor microenvironment in pancreatic cancer
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Samara Singh
Sinha, Surajit
National Cancer Institute
40: Pre-clinical and clinical evaluation of tivozanib for Exportin 7/Ste20-like-kinase (XPO7/SLK)-expressing cholangiocarcinoma
Location:Ballroom B
Surajit Sinha
Sinnamon, Andrew
Moffitt Cancer Institute
97: Long-term Oncologic Outcomes Following Pathologic Complete Response (pCR) for Esophageal Cancer
Location:Ballroom A
Andrew Sinnamon
Skinner, Kristin
University of Rochester Medical Center
Special Surgical Considerations and Approaches
Location:SSO HUB: Breast & Endocrine Zone
Kristin Skinner
Skitzki, Joseph
Roswell Park Comprehensive Cancer Center
Questions and Discussion
Location:Ballroom C
Joseph Skitzki
Stage III (Incl PRADO Approach Discussion)
Location:Ballroom C
Joseph Skitzki
Slavin, Moran
Digestive Health Institute Tampa
101: Robotic Transhiatal Esophagectomy
Location:Veterans Memorial Auditorium
Moran Slavin
99: Technique of IVC Resection and Replacement During Liver Resection
Location:Veterans Memorial Auditorium
Moran Slavin
Smanykó, Viktor
Centre of Radiotherapy, National Institute of Oncology, Budapest, Hungary
12: Impact of imaging-guided localization on performance of tailored axillary surgery in patients with clinically node-positive breast cancer: Prospective study within TAXIS (OPBC-03, SAKK 23/16, IBCSG 57-18, ABCSG-53, GBG 101)
Location:Veterans Memorial Auditorium
Viktor Smanykó
Smith, Benjamin
The University of Texas MD Anderson Cancer Center
5: Extremely Low Incidence of Local-Regional Recurrences Observed Among T1-2 N1 (1 or 2 Positive SLNs) Breast Cancer Patients Receiving Upfront Mastectomy Without Completion Axillary Node Dissection
Location:Veterans Memorial Auditorium
Benjamin Smith
7: Multicenter clinical trial for omission of breast surgery in invasive cancer following neoadjuvant systemic therapy: Longitudinal patient reported outcomes and decisional comfort planned analyses
Location:Veterans Memorial Auditorium
Benjamin Smith
Smith, Franz
Cooperman Barnabas Medical Center RWJ Barabas Health
Skin Cancers in Pigmented Skin - Dermatofibrosarcoma Protuberans
Location:SSO HUB: Melanoma & Sarcoma Zone
Franz Smith
Smith, Frederick
AstraZeneca Industry Forum: Focused Review: Adjuvant Therapy in Certain Patients with HER2-Negative, High-Risk Early Breast Cancer
Location:Room 302
Frederick Smith
Smith, Jesse Joshua
Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College
P20: Microsatellite Instability (MSI): The Transition from Favorable to Unfavorable Outcomes with Lymph Node Metastases
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Jesse Joshua Smith
Surveillance and Treatment of Anal Dysplasia
Location:SSO HUB Theater
Jesse Joshua Smith
Smith, Kathleen
National Cancer Institute
40: Pre-clinical and clinical evaluation of tivozanib for Exportin 7/Ste20-like-kinase (XPO7/SLK)-expressing cholangiocarcinoma
Location:Ballroom B
Kathleen Smith
Smith, Marincola
VUMC
23: Single-cell RNA Sequencing Reveals Distinct Populations of Tumor Associated Macrophages in Colorectal Metastasis.
Location:Ballroom C
Marincola Smith
Smith-Montes, Elizabeth
Memorial Sloan Kettering
19: Sexual Well-being in Patients with Breast Cancer Surgery: Trends, Associated Factors, and Interventions.
Location:Veterans Memorial Auditorium
Elizabeth Smith-Montes
Smith, Myles
The Royal Marsden NHS Foundation trust
P62: Risk Factors for the Development of Early Recurrence in Patients with Primary Retroperitoneal Sarcoma
Location:SSO HUB: Melanoma & Sarcoma Zone
Myles Smith
Smoot, Rory L.
Mayo Clinic, Department of Surgery and Department of Biochemistry and Molecular Biology
51: Response to neoadjuvant chemotherapy in invasive intraductal papillary mucinous cystic neoplasm compared to de novo pancreatic ductal adenocarcinoma
Location:Ballroom A
Rory L. Smoot
P31: Accuracy of DOTATATE PET/CT in the Preoperative Planning of Small Bowel Neuroendocrine Tumor Resection
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Rory L. Smoot
Snelling, Andrew
Norfolk & Norwich University Hospitals NHS Trust, Norwich, UK
59: Validating the Use of Surrogate Endpoints to Assess the Survival Outcomes of Melanoma Patients in Clinical Trials
Location:Veterans Memorial Auditorium
Andrew Snelling
62: Validation of Invasive Area for Predicting Sentinel Node Status and Survival in Melanoma
Location:Veterans Memorial Auditorium
Andrew Snelling
Snyder, Rebecca
UT MD Anderson Cancer Center
43: Optimal Duration of Chemotherapy in the Era of Neoadjuvant Therapy for Pancreatic Adenocarcinoma - Is There a Magic Number?
Location:Ballroom B
Rebecca Snyder
Job Negotiation: The Junior Faculty Perspective
Location:Room 302
Rebecca Snyder
P39: Effect of Surgical Approach on Early Return to Intended Oncologic Therapy After Resection for Pancreatic Ductal Adenocarcinoma
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Rebecca Snyder
P65: A National Assessment of Differences in Gastric Cancer Outcomes Among Asian Ethnic Subgroups
Location:SSO HUB: Rare/Metastatic Cancers Zone
Rebecca Snyder
Quality Poster Presentations
Location:SSO HUB: Rare/Metastatic Cancers Zone
Rebecca Snyder
Shark tank: What’s the Next Big Clinical Trial in Pancreas Cancer
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Rebecca Snyder
Soares, Kevin
Hepatopancreatobiliary Service, Department of Surgery, Memorial Sloan Kettering Cancer Center
27: The Prognostic Value of Pre- and Post-Neoadjuvant Chemotherapy Serum Carcinoembryonic Antigen Levels in Patients Having Resection of Colorectal Liver Metastases
Location:Ballroom C
Kevin Soares
35: Genetic Heterogeneity of Intrahepatic Cholangiocarcinoma: Implications for Outcome
Location:Veterans Memorial Auditorium
Kevin Soares
52: Adjuvant chemotherapy for resected intrahepatic cholangiocarcinoma confers no survival advantage.
Location:Ballroom A
Kevin Soares
Soegaard Ballester, Jacqueline
Department of Surgery, University of Pennsylvania Health System
P23: Resection of the Primary Tumor Improves Survival in Metastatic Adrenocortical Carcinoma
Location:SSO HUB: Breast & Endocrine Zone
Jacqueline Soegaard Ballester
Sofocleous, Constantinos
Memorial Sloan Kettering Cancer Center
37: Hepatic Artery Infusion Chemotherapy Compared to Y90 for Treatment of Unresectable Colorectal Liver Metastases: A Multi-Institutional Comparative Study
Location:Ballroom B
Constantinos Sofocleous
Sohi, Gursharan
Sunnybrook Research Institute
84: The association between familiarity of the surgeon-anesthesiologist dyad and post-operative patient outcomes for complex gastrointestinal cancer surgery: a population-based study.
Location:Ballroom B
Gursharan Sohi
P16: The role of anastomotic leak as a potential high-risk criteria in Stage II colon cancer
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Gursharan Sohi
Soker, Shay
Wake Forest University
66: Utilizing Organoids to Study Perfusate Selection in Appendiceal Cancer Patients Undergoing Repeat HIPEC
Location:Ballroom B
Shay Soker
68: Assessing the Mucolytic and Cytotoxic Activity of Bromelain in Appendiceal Cancer Organoids
Location:Ballroom B
Shay Soker
Sokol, Ethan
Foundation Medicine Inc
11: Genomic Landscape of Malignant Phyllodes Tumors Reveals Multiple Targetable Opportunities
Location:Veterans Memorial Auditorium
Ethan Sokol
Solass, Wiebke
University Hospital Tübingen
P54: A comparative evaluation of efficacy endpoints in colorectal and appendiceal carcinomatosis treated with PIPAC: Secondary analysis of a US multicenter phase 1 trial
Location:SSO HUB: Rare/Metastatic Cancers Zone
Wiebke Solass
Solórzano, Carmen
Vanderbilt University
P21: Utility of near infrared autofluorescence detection of small bowel neuroendocrine tumors to guide extent of resection
Location:SSO HUB: Breast & Endocrine Zone
Carmen Solórzano
P22: Adoption of Robotic Adrenalectomy is Associated with a Short Learning Curve and Improved Outcomes
Location:SSO HUB: Breast & Endocrine Zone
Carmen Solórzano
The Role of Adrenal Metastasectomy in the New Era of Immune Checkpoint Blockade and/or Targeted Therapy
Location:Ballroom C
Carmen Solórzano
Sondak, Vernon
Moffitt Cancer Center
53: Surgical Outcomes of SWOG1801: Neoadjuvant/adjuvant versus adjuvant pembrolizumab for resectable stage III-IV melanoma
Location:Veterans Memorial Auditorium
Vernon Sondak
54: Adjuvant Pembrolizumab in Stage II Melanoma: Outcomes by Tumor Location in the Phase 3 KEYNOTE-716 Study
Location:Veterans Memorial Auditorium
Vernon Sondak
57: Neoadjuvant Pembrolizumab in Stage II-III Desmoplastic Melanoma (SWOG S1512): Surgical Considerations
Location:Veterans Memorial Auditorium
Vernon Sondak
Questions and Discussion
Location:Ballroom C
Vernon Sondak
Stage II (Incl Neoadjuvant, no SLN)
Location:Ballroom C
Vernon Sondak
Song, Brian
University of Michigan
P46: Histotripsy ablation abrogates tumor hypoxia and induces immunogenic cancer cell death
Location:SSO HUB: Melanoma & Sarcoma Zone
Brian Song
Song, Yi
Memorial Sloan Kettering Cancer Center
27: The Prognostic Value of Pre- and Post-Neoadjuvant Chemotherapy Serum Carcinoembryonic Antigen Levels in Patients Having Resection of Colorectal Liver Metastases
Location:Ballroom C
Yi Song
35: Genetic Heterogeneity of Intrahepatic Cholangiocarcinoma: Implications for Outcome
Location:Veterans Memorial Auditorium
Yi Song
Sonka, Milan
University of Iowa College of Engineering
42: Machine-learning based investigation of prognostic indicators for oncological outcome of pancreatic ductal adenocarcinoma
Location:Ballroom B
Milan Sonka
Specht, Michelle
Massachusetts General Hospital
9: Breast cancer-related lymphedema and its relationship to major landmark trials in surgical oncology and radiation oncology
Location:Veterans Memorial Auditorium
Michelle Specht
Spillane, Andrew
Melanoma Institute Australia,
59: Validating the Use of Surrogate Endpoints to Assess the Survival Outcomes of Melanoma Patients in Clinical Trials
Location:Veterans Memorial Auditorium
Andrew Spillane
Spitz, Francis
Cooper University Hospital
10: Epigenetic Drug Therapy Increases Immune Activation and Expression of Genes in the Oncotype Dx Score in Breast Cancer
Location:Veterans Memorial Auditorium
Francis Spitz
Sp, Nipin
The Ohio State University
P57: Phosphorylation of IWS1 by AKT Maintains Liposarcoma Tumor Heterogeneity through Preservation of Cancer Stem Cell Phenotypes and Mesenchymal-Epithelial Plasticity
Location:SSO HUB: Melanoma & Sarcoma Zone
Nipin Sp
Sridhar, Shweta
UTSW
72: Cost Analysis and Financial Implications of Cytoreductive Surgery and HIPEC: a US Single Center Experience
Location:Ballroom B
Shweta Sridhar
Srouji, Rami
Cedars-Sinai Medical Center
P43: Prognostic assessment of sentinel lymph node metastases: Are we using the wrong measure of tumor burden?
Location:SSO HUB: Melanoma & Sarcoma Zone
Rami Srouji
Stacchiotti, Silvia
Fondazione IRCCS Istituto Nazionale dei Tumori
P58: Immune infiltrate of primary retroperitoneal sarcomas (RPS): a prognostic study
Location:SSO HUB: Melanoma & Sarcoma Zone
Silvia Stacchiotti
P64: Surgical management of the duodenum during multivisceral resection for retroperitoneal sarcoma (RPS)
Location:SSO HUB: Melanoma & Sarcoma Zone
Silvia Stacchiotti
Stanisic, Alexander
Northwestern University - Feinberg School of Medicine
P68: The Impact of Digital Inequities on Gastrointestinal Cancer Disparities in the US
Location:SSO HUB: Rare/Metastatic Cancers Zone
Alexander Stanisic
Stanley, Rachael
Norfolk & Norwich University Hospitals NHS Trust, Norwich, UK
62: Validation of Invasive Area for Predicting Sentinel Node Status and Survival in Melanoma
Location:Veterans Memorial Auditorium
Rachael Stanley
Starlinger, Patrick
Division of Hepatobiliary and Pancreas Surgery, Mayo Clinic
P31: Accuracy of DOTATATE PET/CT in the Preoperative Planning of Small Bowel Neuroendocrine Tumor Resection
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Patrick Starlinger
Staudenmayer, Kristan
Stanford University School of Medicine
P75: “Next Gen” Operative Notes – synoptic operative reporting for cancer surgery
Location:SSO HUB: Rare/Metastatic Cancers Zone
Kristan Staudenmayer
Steckly, Kelsey
University of Iowa Hospitals and Clinics
42: Machine-learning based investigation of prognostic indicators for oncological outcome of pancreatic ductal adenocarcinoma
Location:Ballroom B
Kelsey Steckly
Stern, Carrie
Memorial Sloan Kettering
19: Sexual Well-being in Patients with Breast Cancer Surgery: Trends, Associated Factors, and Interventions.
Location:Veterans Memorial Auditorium
Carrie Stern
Stern, Stacey
Saint John's Cancer Institute
61: Smoking imparts shorter disease specific survival in patients with primary cutaneous melanoma
Location:Veterans Memorial Auditorium
Stacey Stern
P43: Prognostic assessment of sentinel lymph node metastases: Are we using the wrong measure of tumor burden?
Location:SSO HUB: Melanoma & Sarcoma Zone
Stacey Stern
P47: Predicting recurrence after a negative sentinel lymph node in melanoma: the model changes with time and sites of recurrence
Location:SSO HUB: Melanoma & Sarcoma Zone
Stacey Stern
Stewart, Camille
University of Colorado Anschutz Medical Center
Melanoma in Pregnancy - Surgical Considerations
Location:SSO HUB Theater
Camille Stewart
P19: Pathological Features Associated With Lymph Node Disease in Patients with Appendiceal Neuroendocrine Tumors.
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Camille Stewart
P77: Prospective Evaluation of a Universally Applied Laparoscopic Gastric Ischemic Preconditioning Protocol Prior to Esophagectomy with Comparison to Historical Controls
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Camille Stewart
Stiles, Brendon
Montefiore Medical Center/ Albert Einstein College of Medicine
P14: ART1, a mono-ADP-ribosyl transferase, is increased by chemotherapy and radiotherapy and is a novel target in colorectal carcinoma.
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Brendon Stiles
Stiles, Zachary
Roswell Park Comprehensive Cancer Institute
P27: Follicular Thyroid Carcinoma with Nodal Metastases: A National Study
Location:SSO HUB: Breast & Endocrine Zone
Zachary Stiles
Stitzenberg, Karyn
University of North Carolina
Non-Operative Management of Rectal Cancer
Location:Ballroom B
Karyn Stitzenberg
Straker, Richard
Hospital of the University of Pennsylvania
58: Timing of Adjuvant Immunotherapy in Stage III Melanoma, Does it Matter?
Location:Veterans Memorial Auditorium
Richard Straker
Strand, Matthew
Atrium Health Carolinas Medical Center
47: Surgical Microwave Ablation for Treatment of Hepatocellular Carcinoma: A Single Institution Review from 2006-2022
Location:Ballroom A
Matthew Strand
Strauss, Dirk
The Royal Marsden Hospital NHS Foundation Trust
P62: Risk Factors for the Development of Early Recurrence in Patients with Primary Retroperitoneal Sarcoma
Location:SSO HUB: Melanoma & Sarcoma Zone
Dirk Strauss
Stretch, Jonathan
Melanoma Institute Australia, Royal North Shore Hospital
59: Validating the Use of Surrogate Endpoints to Assess the Survival Outcomes of Melanoma Patients in Clinical Trials
Location:Veterans Memorial Auditorium
Jonathan Stretch
Strickler, John
Duke University Medical Center
52: Adjuvant chemotherapy for resected intrahepatic cholangiocarcinoma confers no survival advantage.
Location:Ballroom A
John Strickler
Strong, Vivian
Memorial Sloan Kettering Cancer Center
93: Effectiveness of Sentinel Lymph Node Mapping in Gastric Cancer
Location:Ballroom A
Vivian Strong
CON
Location:Veterans Memorial Auditorium
Vivian Strong
P82: Short- and Long- Term Outcomes of Minimally Invasive vs Open Gastrectomy after Neoadjuvant Chemotherapy for Gastric cancer.
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Vivian Strong
Rebuttal and Q&A
Location:Veterans Memorial Auditorium
Vivian Strong
Stuart, Christina
University of Colorado School of Medicine, Department of Surgery
P77: Prospective Evaluation of a Universally Applied Laparoscopic Gastric Ischemic Preconditioning Protocol Prior to Esophagectomy with Comparison to Historical Controls
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Christina Stuart
Stucky, Chee-Chee
Mayo Clinic
Endocrine/H & N and Sarcoma Parallel Session
Location:Ballroom A
Chee-Chee Stucky
P63: Is there a benefit to radiation and surgery in specific histologic subtypes of retroperitoneal sarcoma?
Location:SSO HUB: Melanoma & Sarcoma Zone
Chee-Chee Stucky
Sucandy MD FACS, Iswanto
AdventHealth Tampa
101: Robotic Transhiatal Esophagectomy
Location:Veterans Memorial Auditorium
Iswanto Sucandy MD FACS
99: Technique of IVC Resection and Replacement During Liver Resection
Location:Veterans Memorial Auditorium
Iswanto Sucandy MD FACS
Sugawara, Toshitaka
University of Colorado School of Medicine
P19: Pathological Features Associated With Lymph Node Disease in Patients with Appendiceal Neuroendocrine Tumors.
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Toshitaka Sugawara
Sullivan, Brittany
University of California, Irvine
P49: Convolutional Neural Network to Predict Peritoneal Carcinomatosis Risk in Gastric Cancer
Location:SSO HUB: Rare/Metastatic Cancers Zone
Brittany Sullivan
P50: Novel Vascularized Microtumor (VMT) Model of Peritoneal Carcinomatosis (PC) with Mesothelial-Lined Chambers and Submesothelial Stroma that Mimic the Peritoneal Cavity
Location:SSO HUB: Rare/Metastatic Cancers Zone
Brittany Sullivan
Sullivan, Kevin
City of Hope
P54: A comparative evaluation of efficacy endpoints in colorectal and appendiceal carcinomatosis treated with PIPAC: Secondary analysis of a US multicenter phase 1 trial
Location:SSO HUB: Rare/Metastatic Cancers Zone
Kevin Sullivan
Sumer, Baran
UT Southwestern Medical Center
65: Detection of Residual Peritoneal Metastases Following Cytoreductive Surgery Using Pegsitacianine, a pH Sensitive Imaging Agent: Topline Results from a Phase 2 Study
Location:Veterans Memorial Auditorium
Baran Sumer
Sun, Beatrice
Stanford University School of Medicine
78: Detection of Circulating Tumor DNA Predicts Recurrence in Soft Tissue Sarcomas
Location:Ballroom A
Beatrice Sun
Sun, James
University Hospitals Cleveland Medical Center
31: Factors Predicting Immunotherapy Utilization for Metastatic Merkel Cell Carcinoma from 2015-2018
Location:Ballroom A
James Sun
Sun, Luona
Columbia University Medical Center
P2: Incidence of lymph node involvement in clinically node-negative breast cancer patients following neoadjuvant chemotherapy and identification of clinicopathologic features which may lead to omission of sentinel lymph node biopsy
Location:SSO HUB: Breast & Endocrine Zone
Luona Sun
Sun, Susie
MD Anderson Cancer Center
5: Extremely Low Incidence of Local-Regional Recurrences Observed Among T1-2 N1 (1 or 2 Positive SLNs) Breast Cancer Patients Receiving Upfront Mastectomy Without Completion Axillary Node Dissection
Location:Veterans Memorial Auditorium
Susie Sun
Sun, Virginia
CITY OF HOPE CANCER CENTER
P78: Pilot Study of a Telehealth Intervention for Self-Management of Eating after Gastroesophageal Cancer Surgery
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Virginia Sun
Sun, Xilin
Harbin Medical University, Harbin, China
29: Development of a novel PET agent for parathyroid imaging targeting the Calcium-Sensing Receptor (CaSR)
Location:Ballroom A
Xilin Sun
Sun, Zequn
Northwestern University
45: Differential Immune Signatures are Associated with Racial Disparities in Pancreatic Cancer
Location:Ballroom A
Zequn Sun
Sutradhar, Rinku
University of Toronto
84: The association between familiarity of the surgeon-anesthesiologist dyad and post-operative patient outcomes for complex gastrointestinal cancer surgery: a population-based study.
Location:Ballroom B
Rinku Sutradhar
Swinarska, Joanna
Northwestern University Feinberg School of Medicine
P70: A call for more equitable care in colon cancer: The association between racial and socioeconomic disparities and hospital quality
Location:SSO HUB: Rare/Metastatic Cancers Zone
Joanna Swinarska
Syrnioti, Georgia
New York-Presbyterian Weill Cornell Medicine
P8: Breast Cancer Among Asian Women in New York City: Disparities in Presentation and the Need for Disaggregated Data
Location:SSO HUB: Breast & Endocrine Zone
Georgia Syrnioti
Szabo, Aniko
Medical College of Wisconsin, Department of Biostatistics
87: Identifying Optimal Surgical Timing Relative to SARS-CoV-2 Infection Using COVID-19 Severity in Cancer Patients
Location:Ballroom B
Aniko Szabo
Sze, Daniel
Stanford University
37: Hepatic Artery Infusion Chemotherapy Compared to Y90 for Treatment of Unresectable Colorectal Liver Metastases: A Multi-Institutional Comparative Study
Location:Ballroom B
Daniel Sze
Back to Top
